Dr. Steven W. Tabak, MD

Dr. Tabak practices at Cedars-Sinai Medical Center in Los Angeles, California, part of Cedars-Sinai Health System.

Dr. Tabak's NPI, 1124090576, was assigned on February 1, 2006. Dr. Tabak graduated from The Johns Hopkins University School of Medicine in 1977. Dr. Tabak holds California license G37598.

Dr. Tabak's primary practice is Cedars-Sinai Medical Center, at 8700 Beverly Blvd, Los Angeles, CA 90048 in Los Angeles County. The practice phone is (310) 423-5000.

Dr. Tabak's primary practice is Cedars-Sinai Medical Center in Los Angeles, California, part of Cedars-Sinai Health System. The medical group on file is Cedars-Sinai Medical Group. Dmand AI also links Dr. Tabak to 1 more group practice or clinic, named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Tabak practices, 2 sites in all. Vendor and product names are available with a free account.

Cardiovascular disease is Dr. Tabak's primary specialty in the NPI Registry, under taxonomy code 207RC0000X. Dr. Tabak is board certified in cardiovascular disease by the American Board of Internal Medicine. Dr. Tabak is licensed in California.

Dmand AI lists aneurysm, aortic atherosclerois, atrial fibrillation and flutter, cardiac catheterization, cardiomyopathy, chronic hypertension, coronary artery disease and heart blockage among the conditions Dr. Tabak treats.

CMS data shows 2,328 Medicare services from Dr. Tabak across 11 procedure codes in 2024, for 582 Medicare patients. Medicare paid $183,266 for them. Every service was in an office.

CMS counts 582 Medicare patients who saw Dr. Tabak in 2024. The largest group is 75 to 84, with 274 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 4% are also on Medicaid. Their average risk score is 1.34, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Tabak's median patient age at 77, with 37% women.

In 2024, Dr. Tabak wrote 4,027 Medicare Part D claims for 526 patients. 82% of them were for generic drugs. CMS names the drug for 3,631 of them, across 61 drugs with 11 or more claims each, at $724,646 in total drug cost. In 2023, CMS named 4,381 claims across 70 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 89 out of 100 for Dr. Tabak for performance year 2024, reported as part of a group. Dr. Tabak accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Tabak as offering telehealth.

Dmand AI links 8 papers to Dr. Tabak. The most frequent topics are Coronary Vessels, Constriction, Pathologic and Coronary Angiography. Dr. Tabak has published most often in Am Heart J. Dr. Tabak's most frequent co-authors are Robert J. Siegel, MD, Ellen Klapper, MD and Jon A. Kobashigawa, MD.

CMS Open Payments shows 152 general payments to Dr. Tabak from 28 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 63% of the total. Intuitive Surgical, Inc. paid the most, $3,016.

Dmand AI lists 2 awards for Dr. Tabak.

Dr. Tabak graduated from The Johns Hopkins University School of Medicine in 1977. Dr. Tabak is a member of ACC.

Dr. Tabak is in network with 12 carriers, including Blue Cross Blue Shield of Michigan, Elevance and United Healthcare. PPO plans come from the most carriers, 8. Check the plan with the practice before a visit.